Corporate Profile
Seattle-based Atossa Therapeutics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology. Atossa’s current focus is on breast cancer.
Latest Quarterly Earnings
News Releases
Events
Apr 17, 2024 9:00 AM EDT
Oct 30, 2023 3:00 PM EDT
Sep 28, 2023 9:10 AM EDT
